Stay updated on BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.

Latest updates to the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision label on the Record History page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision history updated to show v3.4.2 added and v3.4.1 removed.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded a new revision entry v3.4.1 to the study history. Removed the previous revision v3.4.0.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page history now shows a new revision v3.3.4 and removes v3.3.3 from the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedA new revision note (v3.3.3) was added and an older revision note (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These changes reflect administrative footer updates.SummaryDifference0.1%

- Check113 days agoChange DetectedSite version updated from v3.2.0 to v3.3.2; no visible changes to trial data or the Record History page.SummaryDifference0.0%

Stay in the know with updates to BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836909 Dose Escalation in Last Line Multiple Myeloma Clinical Trial page.